Table 2.
Group I n = 16 |
Group II n = 36 |
p | |
---|---|---|---|
Mean ± SD | Mean ± SD | ||
AIP (regular formula)_1 | 0.18 ± 0.21 | 0.37 ± 0.27 | 0.011 * |
AIP (regular formula)_2 | 0.23 ± 0.21 | 0.22 ± 0.25 | ns |
delta AIP (regular formula) | 0.05 ± 0.10 | −0.16 ± 0.14 | ≤0.001 *** |
AIP (new formula)_1 | 0.65 ± 0.26 | 1.02 ± 0.37 | ≤0.001 *** |
AIP (new formula)_2 | 0.75 ± 0.29 | 0.73 ± 0.30 | ns |
delta AIP (new formula) | 0.09 ± 0.08 | −0.29 ± 0.18 | ≤0.001 *** |
Group I: patients with an increase in AIP; Group II: patients with a decrease in AIP; AIP: atherogenic index of plasma; SD: standard deviation; p: p value of a two-sample t-test, assuming or not assuming equal variances based on Levene’s Test for Equality of Variances; *: p ≤ 0.050; ***: p ≤ 0.001; _1: value before body mass reduction; _2: value after body mass reduction; ns—not significant result.